Patents by Inventor David BRYSON

David BRYSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12614353
    Abstract: Areas of interest on three-dimensional maps can be made visually distinct using three-dimensional tint band meshes that overlay other three-dimensional meshes, for example three-dimensional meshes providing terrain, elevation, and infrastructure data. Characteristics of the three-dimensional tint band meshes may be dynamically updated for visual distinctiveness. When overlaying three-dimensional tint band meshes, the overlay operation can use connectivity information of the three-dimensional meshes to increase performance.
    Type: Grant
    Filed: December 5, 2022
    Date of Patent: April 28, 2026
    Assignee: Apple Inc.
    Inventors: Syed Mohsin Hasan, David Bryson, Vikram M. Puttichanda, Miguel C. Vieira, Daniel W. Zaide
  • Publication number: 20260062704
    Abstract: Compositions and methods for editing a pathogenic ATP-binding cassette, subfamily A, member 4 (ABCA4) polypeptide-encoding gene using an adenosine deaminase base editor to treat a congenital eye disorder, such as Stargardt disease. In various embodiments, the disclosure provides methods for altering a nucleobase (e.g., c.4139T) in an ABCA4 gene codon 1380 encoding a pathogenic leucine so that the codon is altered to encode a proline. In some embodiments, the disclosure provides methods for altering a pathogenic c.5714+5A intronic nucleotide of anABCA4 gene so that the nucleotide becomes c.5714+5G.
    Type: Application
    Filed: October 27, 2025
    Publication date: March 5, 2026
    Applicant: Beam Therapeutics Inc.
    Inventors: Jack Sullivan, David Bryson, Luis Fernando Camarillo Guerrero
  • Patent number: 12529041
    Abstract: The invention provides compositions and methods for delivering first and second polynucleotides each encoding a fragment of an A-to-G Base Editor fusion protein comprising one or more deaminases (e.g., adenosine deaminases) and nCas9, wherein the first polynucleotide encodes an N-terminal fragment of nCas9 fused to an intein-N of a split intein pair and the second polynucleotide encodes a C-terminal fragment of nCas9 fused to an intein-C of a split intein pair, and methods for delivering these fragments together with an sgRNA to a cell (e.g., AAV delivery), where the fragments are spliced together by a split intein system, thereby reconstituting a functional base editing system in the cell.
    Type: Grant
    Filed: September 7, 2019
    Date of Patent: January 20, 2026
    Assignee: Beam Therapeutics Inc.
    Inventor: David Bryson
  • Publication number: 20250354138
    Abstract: This disclosure provides compositions and methods for the editing of a SERPINA1 gene with prime editing.
    Type: Application
    Filed: March 14, 2025
    Publication date: November 20, 2025
    Inventors: Maria Montiel, Ayan Banerjee, Brian Cafferty, James Tam, David Bryson, Markrete Krikorian
  • Publication number: 20250223587
    Abstract: The present disclosure features compositions and methods for editing a 290-KD centrosomal protein (CEP290) gene to treat a congenital eye disorder, such as Leber's Congenital Amaurosis-10. In embodiments, the disclosure provides methods for direct correction of the IVS26 pathogenic mutation in the CEP290 gene (CEP290 c.2991+1655A>G) and/or disruption of a cryptic splice donor site within an intron of the CEP290 gene using a base editor (e.g., a cytidine deaminase base editor, an adenosine deaminase base editor, or a cytidine adenosine deaminase base editor (CABE)).
    Type: Application
    Filed: January 22, 2025
    Publication date: July 10, 2025
    Applicant: Beam Therapeutics Inc.
    Inventors: David Bryson, Jack Sullivan
  • Publication number: 20250108098
    Abstract: Provided herein are compositions and methods of using base editors comprising a polynucleotide programmable nucleotide binding domain and a nucleobase editing domain in conjunction with a guide polynucleotide. Also provided herein are base editor systems for editing nucleobases of target nucleotide sequences.
    Type: Application
    Filed: August 16, 2024
    Publication date: April 3, 2025
    Applicant: Beam Therapeutics Inc.
    Inventors: David Bryson, John Evans, Michael Packer, Yanfang Fu, Nicole Gaudelli, Jason Michael Gehrke, J. Keith Joung
  • Publication number: 20250092450
    Abstract: Provided herein includes high-throughput methods for in vivo screening nanoparticles (e.g., lipid nanoparticles) for preferential delivery to a target tissue or cell type. Also provided are compositions used in the high-throughput nanoparticle screening method.
    Type: Application
    Filed: November 26, 2024
    Publication date: March 20, 2025
    Inventors: Nicholas JUSTICE, Courtney WONG, David BRYSON, Valentina Laclare MCENEANY, Maya SEN, Cory D. SAGO, Kathryn MURRAY
  • Publication number: 20250012593
    Abstract: In some embodiments, an electronic device present navigation routes from various perspectives. In some embodiments, an electronic device modifies display of representations of (e.g., physical) objects in the vicinity of a navigation route while presenting navigation directions. In some embodiments, an electronic device modifies display of portions of a navigation route that are occluded by representations of (e.g., physical) objects in a map. In some embodiments, an electronic device presents representations of (e.g., physical) objects in maps. In some embodiments, an electronic device presents representations of (e.g., physical) objects in maps in response to requests to search for (e.g., physical) objects.
    Type: Application
    Filed: September 20, 2024
    Publication date: January 9, 2025
    Inventors: Ryan W. APUY, Brian J. ANDRICH, Jaime CHEN, Leo Emile Jean Pierre VALLET, Giovanni S. LUIS, Sarah A. BERGQUIST, Benjamin R. DREYER, Rachel A. SMITH, Aaron P. DENNIS, Richard A. SMALL, David BRYSON, Brian R. FRICK, Mikio INOSE, Zhivko B. TERZIIVANOV, Steven C. BEEBY, Ryan DIGNARD, David UNGUREAN
  • Patent number: 12133884
    Abstract: Provided herein are compositions and methods of using base editors comprising a polynucleotide programmable nucleotide binding domain and a nucleobase editing domain in conjunction with a guide polynucleotide. Also provided herein are base editor systems for editing nucleobases of target nucleotide sequences.
    Type: Grant
    Filed: May 11, 2019
    Date of Patent: November 5, 2024
    Assignee: Beam Therapeutics Inc.
    Inventors: David Bryson, John Evans, Michael Packer, Yanfang Fu, Nicole Gaudelli, Jason Michael Gehrke, J. Keith Joung
  • Publication number: 20240132868
    Abstract: The invention features polynucleotides that encode bases editors having a heterologous intron for self-inactivation, compositions comprising such polynucleotides, and methods of inactivating a base editor encoded by such polynucleotides.
    Type: Application
    Filed: November 27, 2023
    Publication date: April 25, 2024
    Applicant: Beam Therapeutics Inc.
    Inventors: David BRYSON, Jack SULLIVAN
  • Publication number: 20230368469
    Abstract: Areas of interest on three-dimensional maps can be made visually distinct using three-dimensional tint band meshes that overlay other three-dimensional meshes, for example three-dimensional meshes providing terrain, elevation, and infrastructure data. Characteristics of the three-dimensional tint band meshes may be dynamically updated for visual distinctiveness. When overlaying three-dimensional tint band meshes, the overlay operation can use connectivity information of the three-dimensional meshes to increase performance.
    Type: Application
    Filed: December 5, 2022
    Publication date: November 16, 2023
    Applicant: Apple Inc.
    Inventors: Syed Mohsin Hasan, David Bryson, Vikram M. Puttichanda, Miguel C. Vieira, Daniel W. Zaide
  • Publication number: 20230159956
    Abstract: Provided herein are compositions and methods of using base editors comprising a polynucleotide programmable nucleotide binding domain and a nucleobase editing domain in conjunction with a guide polynucleotide. Also provided herein are base editor systems for editing nucleobases of target nucleotide sequences.
    Type: Application
    Filed: May 11, 2019
    Publication date: May 25, 2023
    Applicant: Beam Therapeutics Inc.
    Inventors: David Bryson, John Evans, Michael Packer, Jason Michael Gehrke, Natalie Petrossian
  • Publication number: 20220401530
    Abstract: Provided herein are compositions and methods of using base editors comprising a polynucleotide programmable nucleotide binding domain and a nucleobase editing domain in conjunction with a guide polynucleotide. Also provided herein are base editor systems for editing nucleobases of target nucleotide sequences.
    Type: Application
    Filed: May 11, 2019
    Publication date: December 22, 2022
    Applicant: Beam Therapeutics Inc.
    Inventors: David Bryson, John Evans, Michael Packer, Yanfang Fu, Nicole Gaudelli, Jason Michael Gehrke, J. Keith Joung
  • Publication number: 20210380955
    Abstract: The invention features compositions and methods for altering mutations associated with Rett Syndrome (RTT). Provided herein are compositions and methods of using base editors comprising a polynucleotide programmable nucleotide binding domain and a nucleobase editing domain in conjunction with a guide polynucleotide. Also provided herein are base editor systems for editing nucleobases of target nucleotide sequences.
    Type: Application
    Filed: May 11, 2019
    Publication date: December 9, 2021
    Applicant: Beam Therapeutics Inc.
    Inventors: David Bryson, John Evans, Michael Packer, Jason Michael Gehrke, Natalie Petrossian
  • Publication number: 20210301274
    Abstract: The invention provides compositions and methods for delivering first and second polynucleotides each encoding a fragment of an A-to-G Base Editor fusion protein comprising one or more deaminases (e.g., adenosine deaminases) and nCas9, wherein the first polynucleotide encodes an N-terminal fragment of nCas9 fused to an intein-N of a split intein pair and the second polynucleotide encodes a C-terminal fragment of nCas9 fused to an intein-C of a split intein pair, and methods for delivering these fragments together with an sgRNA to a cell (e.g., AAV delivery), where the fragments are spliced together by a split intein system, thereby reconstituting a functional base editing system in the cell.
    Type: Application
    Filed: September 7, 2019
    Publication date: September 30, 2021
    Applicant: Beam Therapeutics Inc.
    Inventor: David Bryson
  • Patent number: 11080399
    Abstract: A system and method for implementing a software emulation environment is provided. In one example, a mobile application can interface with an emulation environment that can be used to test whether the mobile application includes malware that can compromise the security and integrity of an enterprise's computing infrastructure. When the mobile application issues a call for data, a device mimic module can intercept the call and determine if the call includes a call for one or more checkable artifacts that can reveal the existence of the emulation environment. If such a call for data occurs, the device mimic module can provide one or more spoofed checkable artifacts that have been recorded from a real-world mobile device. In this way, the existence of the emulation environment can be concealed so as to allow for a more thorough analysis of a mobile application for potential hidden malware.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: August 3, 2021
    Assignee: The MITRE Corporation
    Inventors: David Keppler, Ivan Lozano, Joseph Portner, Andrew Pyles, Christina L. Johns, David Bryson
  • Publication number: 20200125730
    Abstract: A system and method for implementing a software emulation environment is provided. In one example, a mobile application can interface with an emulation environment that can be used to test whether the mobile application includes malware that can compromise the security and integrity of an enterprise's computing infrastructure. When the mobile application issues a call for data, a device mimic module can intercept the call and determine if the call includes a call for one or more checkable artifacts that can reveal the existence of the emulation environment. If such a call for data occurs, the device mimic module can provide one or more spoofed checkable artifacts that have been recorded from a real-world mobile device. In this way, the existence of the emulation environment can be concealed so as to allow for a more thorough analysis of a mobile application for potential hidden malware.
    Type: Application
    Filed: December 19, 2019
    Publication date: April 23, 2020
    Applicant: The MITRE Corporation
    Inventors: David KEPPLER, Ivan LOZANO, Joseph PORTNER, Andrew PYLES, Christina L. JOHNS, David BRYSON
  • Patent number: 10528734
    Abstract: A system and method for implementing a software emulation environment is provided. In one example, a mobile application can interface with an emulation environment that can be used to test whether the mobile application includes malware that can compromise the security and integrity of an enterprise's computing infrastructure. When the mobile application issues a call for data, a device mimic module can intercept the call and determine if the call includes a call for one or more checkable artifacts that can reveal the existence of the emulation environment. If such a call for data occurs, the device mimic module can provide one or more spoofed checkable artifacts that have been recorded from a real-world mobile device. In this way, the existence of the emulation environment can be concealed so as to allow for a more thorough analysis of a mobile application for potential hidden malware.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: January 7, 2020
    Assignee: The MITRE Corporation
    Inventors: David Keppler, Ivan Lozano, Joseph Portner, Andrew Pyles, Christina L. Johns, David Bryson
  • Patent number: 10419486
    Abstract: Systems and methods for managing and implementing secure runtime software hooking on devices are provided. The system and method disclosed includes components and features that enable enterprises and organizations to securely manage mobile devices that have access to the organization's data and network resources. Various embodiments provide for secure systems and methods to modify a behavior of an operating system or one or more applications, without having to flash or modify the Read-only Memory (ROM).
    Type: Grant
    Filed: October 11, 2016
    Date of Patent: September 17, 2019
    Assignee: The MITRE Corporation
    Inventors: Joseph Portner, Colin Courtney, David Bryson, Sarah Ford, Collin McRae
  • Publication number: 20170277891
    Abstract: A system and method for implementing a software emulation environment is provided. In one example, a mobile application can interface with an emulation environment that can be used to test whether the mobile application includes malware that can compromise the security and integrity of an enterprise's computing infrastructure. When the mobile application issues a call for data, a device mimic module can intercept the call and determine if the call includes a call for one or more checkable artifacts that can reveal the existence of the emulation environment. If such a call for data occurs, the device mimic module can provide one or more spoofed checkable artifacts that have been recorded from a real-world mobile device. In this way, the existence of the emulation environment can be concealed so as to allow for a more thorough analysis of a mobile application for potential hidden malware.
    Type: Application
    Filed: March 25, 2016
    Publication date: September 28, 2017
    Applicant: The MITRE Corporation
    Inventors: David KEPPLER, Ivan LOZANO, Joseph PORTNER, Andrew PYLES, Christina L. JOHNS, David BRYSON